BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15363304)

  • 21. Serum carcinoembryonic antigen level in pN1 non-small cell lung cancer patients.
    Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Anticancer Res; 2005; 25(5):3601-5. PubMed ID: 16101187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum carcinoembryonic antigen level as a surrogate marker for the evaluation of tumor response to chemotherapy in nonsmall cell lung cancer.
    Ishiguro F; Fukui T; Mori S; Katayama T; Sakakura N; Hatooka S; Mitsudomi T
    Ann Thorac Cardiovasc Surg; 2010 Aug; 16(4):242-7. PubMed ID: 21057440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinically predictive factors of pathologic upstaging in patients with peripherally located clinical stage IA non-small cell lung cancer.
    Yamazaki K; Yoshino I; Yohena T; Kameyama T; Tagawa T; Kawano D; Oba T; Koso H; Maehara Y
    Lung Cancer; 2007 Mar; 55(3):365-9. PubMed ID: 17267071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis.
    Matsuguma H; Nakahara R; Igarashi S; Ishikawa Y; Suzuki H; Miyazawa N; Honjo S; Yokoi K
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):44-9. PubMed ID: 18179917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid.
    Tsutani Y; Yamashita Y; Misumi K; Ikeda T; Miyata Y; Okada M
    Eur J Cardiothorac Surg; 2012 Nov; 42(5):e96-101. PubMed ID: 22906597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
    Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
    Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer.
    Tomita M; Shimizu T; Ayabe T; Yonei A; Onitsuka T
    Anticancer Res; 2010 Jul; 30(7):3099-102. PubMed ID: 20683062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer.
    Chantapet P; Riantawan P; Lebnak P; Getngern P
    J Med Assoc Thai; 2000 Apr; 83(4):383-91. PubMed ID: 10808698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour CEA as predictor of better outcome in squamous cell carcinoma of the lung.
    Veronesi G; Pelosi G; Sonzogni A; Leon ME; D'Aiuto M; Gasparri R; De Braud F; De Pas T; Sandri M; Spaggiari L
    Lung Cancer; 2005 May; 48(2):233-40. PubMed ID: 15829323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA test.
    Buccheri G; Ferrigno D
    Ann Thorac Surg; 2003 Mar; 75(3):973-80. PubMed ID: 12645726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
    Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer.
    Suzuki H; Ishikawa S; Satoh H; Ishikawa H; Sakai M; Yamamoto T; Onizuka M; Sakakibara Y
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):648-52. PubMed ID: 17707649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer.
    Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Kameyama M; Suehiro S
    Ann Thorac Surg; 2007 Jan; 83(1):216-21. PubMed ID: 17184666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
    Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):76-80. PubMed ID: 15209547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of the serum carcinoembryonic antigen level during the follow-up of patients with completely resected non-small-cell lung cancer.
    Ozeki N; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ito S; Sakao Y; Mitsudomi T; Hirakawa A; Yokoi K
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):687-92. PubMed ID: 23979987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
    Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
    J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients.
    Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Anticancer Res; 2008; 28(3B):1947-50. PubMed ID: 18630486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum tissue inhibitors of metalloproteinase-1 and -2 in patients with non-small cell lung cancer.
    Suemitsu R; Yoshino I; Tomiyasu M; Fukuyama S; Okamoto T; Maehara Y
    Surg Today; 2004; 34(11):896-901. PubMed ID: 15526122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.